Which of the following SSRI's is approved for use in pediatrics?

Escitalopram is the correct choice because it has been specifically studied and approved for use in pediatric patients, particularly for the treatment of major depressive disorder and generalized anxiety disorder in children and adolescents. The approval process for medications involves rigorous testing to ensure safety and efficacy in specific populations, and escitalopram has met these criteria for young patients.

Citalopram, while also an SSRI, has not received the same level of specific pediatric approval as escitalopram. Paroxetine is generally avoided in children due to concerns about safety and side effects in this age group. Duloxetine, although an effective antidepressant, is classified as an SNRI (serotonin-norepinephrine reuptake inhibitor) and has not been approved for use in pediatric patients. Thus, escitalopram stands out for its approved status and demonstrated effectiveness in treating depression and anxiety disorders in the younger population.